Joyce Liu, MD

Trials

Studies that name Joyce Liu, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:59 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06369155 · Azenosertib in Uterine Serous Carcinoma: Biomarker Study

  Joyce Liu, MD · recruiting · Uterine Serous Carcinoma, Uterine Carcinoma, Uterine Cancer · principal investigator
• Ph2
  NCT04590248 · A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

  AstraZeneca · completed · Uterine Serous Carcinoma · principal investigator
• Ph2
  NCT03668340 · AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma

  Dana-Farber Cancer Institute · active not recruiting · Uterine Cancer · principal investigator
• Ph2
  NCT02873962 · A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

  Dana-Farber Cancer Institute · active not recruiting · Peritoneal Cancer, Ovarian Cancer, Fallopian Tube Cancer · principal investigator
• Ph1
  NCT02661815 · A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

  Dana-Farber Cancer Institute · terminated · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 03:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.